Validation of the UK myeloma research alliance risk profile, a new clinical prediction model for outcome in patients with newly diagnosed multiple myeloma not eligible for autologous stem cell transplantation; a population‐based study from the Danish national multiple myeloma registry-Reference-Cited by-同舟云学术

Validation of the UK myeloma research alliance risk profile, a new clinical prediction model for outcome in patients with newly diagnosed multiple myeloma not eligible for autologous stem cell transplantation; a population‐based study from the Danish national multiple myeloma registry

Published:2020-06-09 Issue:1 Volume:193 Page:119-124
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br. J. Haematol.

Author:

Redder Louise¹^ORCID,Klausen Tobias W.²^ORCID,Vangsted Annette Juul³^ORCID,Gregersen Henrik⁴^ORCID,Andersen Niels F.⁵,Pedersen Robert S.⁶,Szabo Agoston G.⁷^ORCID,Frederiksen Mikael⁸,Frølund Ulf C.⁹,Helleberg Carsten²,Nielsen Lene Kongsgaard¹¹⁰^ORCID,Pedersen Per T.¹¹,Salomo Morten³,Gimsing Peter³^ORCID,Frederiksen Henrik¹¹²¹³^ORCID,Abildgaard Niels¹¹²¹³^ORCID

Affiliation:

1. Department of Haematology Odense University Hospital OdenseDenmark

2. Department of Haematology Herlev Hospital HerlevDenmark

3. Department Haematology Copenhagen University Hospital Rigshospitalet, CopenhagenDenmark

4. Department of Haematology Aalborg University Hospital AalborgDenmark

5. Department of Haematology Aarhus University Hospital AarhusDenmark

6. Department of Haematology Holstebro Hospital HolstebroDenmark

7. Department of Haematology Vejle Hospital VejleDenmark

8. Department of Haematology Hospital of Southern Jutland AabenraaDenmark

9. Department of Haematology Zealand University Hospital RoskildeDenmark

10. Department of Internal Medicine and Cardiology Regional Hospital Viborg Denmark

11. Department of Haematology South‐Western Hospital EsbjergDenmark

12. Academy of Geriatric Cancer Research (AgeCare)Odense University Hospital OdenseDenmark

13. Department of Clinical Research University of Southern Denmark OdenseDenmark

Funder

Kræftens Bekæmpelse

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16806

Reference13 articles.

1. Multiple myeloma: 2018 update on diagnosis, risk-stratification, and management

2. International Staging System for Multiple Myeloma

3. Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

4. PalumboA BringhenS MateosM LaroccaA FaconT KumarS et al.Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report.2015;125:2068–74.

5. A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Haemato‐Oncology Frailty (HOF) score to assess frailty in lymphoma;European Journal of Haematology;2023-12-19

2. New Strategies for the Treatment of Older Myeloma Patients;Cancers;2023-05-10

3. Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic;Blood Cancer Journal;2023-03-15

4. Frail Multiple Myeloma Patients Deserve More Than Just a Score;Hematology Reports;2023-02-21

5. Prognostic impact of the UK Myeloma Research Alliance Risk Profile in transplant‐ineligible patients with multiple myeloma who received a melphalan, prednisolone, and bortezomib regimen: A supplementary analysis of JCOG1105;Hematological Oncology;2022-11-30